top of page

GPCR News 

Post: Blog2_Post

Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...

December 2021


Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed President of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) earlier this month. Coincidentally, on the same day, Prof Pfleger was announced as a Fellow of the British Pharmacological Society.


"ASCEPT is the peak professional society devoted to advancing excellence in Clinical and Experimental Pharmacology and Toxicology in Australia and New Zealand. Established in 1966, ASCEPT is affiliated with the International Union of Basic and Clinical Pharmacology (IUPHAR) and the International Union of Toxicology (IUTOX). Prof Pfleger has served on the ASCEPT Board since 2016 and was Chair of the Scientific Advisory Committee in 2017 and 2018.

“I am honoured to be appointed President of ASCEPT, and am particularly excited given the Society’s conference will be held in Perth next year, in collaboration with the Australasian Pharmaceutical Science Association (APSA).”"


3 views0 comments

Recent Posts

See All

Amgen to Acquire Chemocentryx for $4 Billion in Cash

August 2022 "THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and ChemoCentryx, Inc., (NASDAQ: CCXI), a biopharmaceutical company focused on orally admin

Comentarios